Anzeige
Mehr »
Login
Montag, 17.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien
Suchen Sie auch nach Fosterville South (A2QJKK)? Hier gibt´s News!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 852738 ISIN: BE0003739530 Ticker-Symbol: UNC 
Tradegate
17.05.21
16:19 Uhr
79,34 Euro
+2,04
+2,64 %
Branche
Pharma
Aktienmarkt
EURONEXT-100
BEL-20
1-Jahres-Chart
UCB SA Chart 1 Jahr
5-Tage-Chart
UCB SA 5-Tage-Chart
RealtimeGeldBriefZeit
79,2879,6021:00
79,3679,6021:00

Aktuelle News zur UCB Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
UCB Aktie jetzt für 0€ handeln
26.03.UCB SA/NV - Convening notice annual shareholders meeting397*** Unofficial English translation - For convenience purposes only *** UCB SA/NV - Public Limited Liability CompanyAllée de la Recherche 60, 1070 BrusselsEnterprise nr. 0403.053.608 (RLE Brussels)www.ucb.com("UCB...
► Artikel lesen
09.03.Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs422Insilico Medicine announces that UCB will integrate its AI-based system for de novo molecular design, Chemistry42, into its drug discovery programs HONG KONG, March 9, 2021 /PRNewswire/...
► Artikel lesen
28.02.UCB SA (UCBJF) CEO Jean-Christophe Tellier on Q4 2020 Results - Earnings Call Transcript19
25.02.UCB SA reports FY results13
25.02.UCB Full Year Report 2020: UCB - sustaining growth, now and into the future555· Revenue increased to € 5.3 billion (+9%, +8% CER[1]) net sales to € 5.1 billion (+8%, +7% CER) · Underlying profitability (adj. EBITDA[2]) was € 1.4 billion (+1%, -4% CER) or 27%...
► Artikel lesen
24.02.UCB expands partnership with Microsoft to speed up drug development12
24.02.UCB taps Microsoft to accelerate drug discovery, clinical trials4
23.02.UCB builds on relationship with Microsoft with new AI deal; Sanofi partners with German AAV vector biotech11
23.02.UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development400BRUSSELS and ATLANTA, Feb. 23, 2021 /PRNewswire/ -- Through this collaboration with Microsoft, UCB seeks to discover and develop medicines faster for people living with severe diseases...
► Artikel lesen
05.02.UCB's bimekizumab data in plaque psoriasis published in The Lancet12
15.01.Im heutigen Aktientriple: ROCHE, UCB & der europäische Chemiesektor58
13.01.UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy345- Nile is developing a digital epilepsy care management platform and bringing together data to make the epilepsy journey predictable - UCB invested €25 million ($29.3 million) and as...
► Artikel lesen
02.12.20Amgen, Takeda, UCB enrol first patient in Covid-19 global platform study25
01.12.20Amgen, Takeda and UCB join forces in new COVID-19 drug repurposing study6
01.12.20Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda12
30.11.20COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs15
20.11.20Briviact: Adapter passt in Einzelfällen nicht in die Flaschenöffnung: UCB Pharma informiert darüber, ...5
19.11.20doc.ai and UCB Biopharma Team Up to Develop Breakthrough Artificial Intelligence Models to Advance Care287New digital health trial will leverage state-of-the-art tech to detect and predict myasthenia gravis symptom patterns and flares doc.ai, an enterprise AI platform accelerating digital transformation...
► Artikel lesen
12.11.20Lacerta Therapeutics Signs Gene Therapy Research Partnership with UCB345New research collaboration and licensing agreement with Lacerta provides UCB access to a novel gene therapy program and proprietary AAV capsids ALACHUA, FL / ACCESSWIRE / November 12, 2020 / Lacerta...
► Artikel lesen
07.10.20UCB and Aetion Announce Agreement to Enhance Real-World Evidence Generation to Advance Value-Based Contracts361UCB will utilize Aetion's analytics platform to align with U.S. payers on treatment outcomes and value NEW YORK, Oct. 7, 2020 /PRNewswire/ -- Today, Aetion and UCB announced a new agreement...
► Artikel lesen
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1